Association of a Deletion of GSTT2B with an Altered Risk of Oesophageal Squamous Cell Carcinoma in a South African Population: A Case-Control Study

• Marco Matejcic,

  Affiliations International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Observatory, Cape Town, South Africa, Division of Medical Biochemistry and IIDMM, UCT Faculty of Health Sciences, Cape Town, South Africa

  ⨯
• DongPing Li,

  Affiliations International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Observatory, Cape Town, South Africa, Division of Medical Biochemistry and IIDMM, UCT Faculty of Health Sciences, Cape Town, South Africa

  ⨯
• Natalie J. Prescott,

  Affiliation Department of Medical and Molecular Genetics, King's College London, King's Health Partners, Guy's Hospital, London, United Kingdom

  ⨯
• Cathryn M. Lewis,

  Affiliations Department of Medical and Molecular Genetics, King's College London, King's Health Partners, Guy's Hospital, London, United Kingdom, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom

  ⨯
• Christopher G. Mathew,

  Affiliation Department of Medical and Molecular Genetics, King's College London, King's Health Partners, Guy's Hospital, London, United Kingdom

  ⨯
• M. Iqbal Parker

  * E-mail: iqbal.parker@uct.ac.za

  Affiliations International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Observatory, Cape Town, South Africa, Division of Medical Biochemistry and IIDMM, UCT Faculty of Health Sciences, Cape Town, South Africa

  ⨯